Primary Site >> Stomach Cancer

Gene >> SLC44A4

Journal: Invest New Drugs. 2016 Jun;34(3):319-28.
Title: A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.
Author: Coveler, Andrew L|Ko, Andrew H|Catenacci, Daniel V T|Von Hoff, Daniel|Becerra, Carlos|Whiting, Nancy C|Yang, Jing|Wolpin, Brian
PMID: 26994014